Evaluation of the Aurora Kinase Inhibitor, ZM447439, in Canine Malignant Lymphoid Cells <i>in Vitro</i>

Journals Menu

Follow SCIRP

ISSN Print: 2165-3356
ISSN Online: 2165-3364
www.scirp.org/journal/ojvm
E-mail: ojvm@scirp.org

Citations h5-index & Ranking*

"Evaluation of the Aurora Kinase Inhibitor, ZM447439, in Canine Malignant Lymphoid Cells in Vitro"
written by Keijiro Shiomitsu, Xueqing Xia, Kyle Waite, Inder Sehgal, Shulin Li,
published by Open Journal of Veterinary Medicine, Vol.3 No.1, 2013

has been cited by the following article(s):

[1]	Disrupting inhibitory-kappaB kinase (IKK)-Aurora kinase signalling in prostate cancer cells
	2021

[2]	Comprehensive genomic characterization of five canine lymphoid tumor cell lines
	2016

[3]	Aurora 激酶及其抑制剂研究进展
	国外医药：抗生素分册, 2016

[4]	The radiosensitizing effect of the aurora kinase inhibitors, ENMD‐2076, on canine mast cell tumours in vitro
	Veterinary and comparative oncology, 2013

[1]	Protein Kinase Inhibitors 2022 DOI:10.1016/B978-0-323-91287-7.00028-4

[2]	The radiosensitizing effect of the aurora kinase inhibitors, ENMD-2076, on canine mast cell tumoursin vitro Veterinary and Comparative Oncology, 2016 DOI:10.1111/vco.12046

[3]	Comprehensive genomic characterization of five canine lymphoid tumor cell lines BMC Veterinary Research, 2016 DOI:10.1186/s12917-016-0836-z

Follow SCIRP